SI2446884T1 - Sestavek za inhibiranje vnetja, ki obsega hialuronsko kislino in HMG-CoA reduktazni inhibitor - Google Patents
Sestavek za inhibiranje vnetja, ki obsega hialuronsko kislino in HMG-CoA reduktazni inhibitorInfo
- Publication number
- SI2446884T1 SI2446884T1 SI201130266T SI201130266T SI2446884T1 SI 2446884 T1 SI2446884 T1 SI 2446884T1 SI 201130266 T SI201130266 T SI 201130266T SI 201130266 T SI201130266 T SI 201130266T SI 2446884 T1 SI2446884 T1 SI 2446884T1
- Authority
- SI
- Slovenia
- Prior art keywords
- hmg
- composition
- hyaluronic acid
- coa reductase
- reductase inhibitor
- Prior art date
Links
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 title 1
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 title 1
- 206010061218 Inflammation Diseases 0.000 title 1
- 229920002674 hyaluronan Polymers 0.000 title 1
- 229960003160 hyaluronic acid Drugs 0.000 title 1
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 title 1
- 230000004054 inflammatory process Effects 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW099137186A TWI382841B (zh) | 2010-10-29 | 2010-10-29 | 用於抑制發炎之醫藥組合物 |
| EP11181939.7A EP2446884B1 (en) | 2010-10-29 | 2011-09-20 | Composition for inhibiting inflammation comprising hyaluronic acid and a hmg-coa reductase inhibitor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI2446884T1 true SI2446884T1 (sl) | 2014-10-30 |
Family
ID=44719407
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI201130266T SI2446884T1 (sl) | 2010-10-29 | 2011-09-20 | Sestavek za inhibiranje vnetja, ki obsega hialuronsko kislino in HMG-CoA reduktazni inhibitor |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US8691796B2 (sl) |
| EP (1) | EP2446884B1 (sl) |
| JP (1) | JP5513430B2 (sl) |
| CN (1) | CN102462843A (sl) |
| DK (1) | DK2446884T3 (sl) |
| ES (1) | ES2501040T3 (sl) |
| HK (1) | HK1166468A1 (sl) |
| HR (1) | HRP20140842T1 (sl) |
| PL (1) | PL2446884T3 (sl) |
| PT (1) | PT2446884E (sl) |
| RS (1) | RS53546B1 (sl) |
| SI (1) | SI2446884T1 (sl) |
| TW (1) | TWI382841B (sl) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5751206B2 (ja) | 2011-10-21 | 2015-07-22 | 株式会社豊田中央研究所 | 光偏向装置 |
| CN107613972B (zh) * | 2015-06-18 | 2020-11-24 | 高雄医学大学 | 一种医药组合物用于制备促进软骨细胞生成的药物的用途 |
| CA3025208A1 (en) * | 2016-05-24 | 2017-11-30 | Bol Pharma Ltd. | Compositions comprising cannabidiol and hyaluronic acid for treating inflammatory joint diseases |
| US10149868B2 (en) * | 2016-05-31 | 2018-12-11 | Tco Co., Ltd. | Use of Streptococcus thermophilis TCI633 in treating arthritis |
| FR3062797A1 (fr) * | 2017-02-10 | 2018-08-17 | Centre Hospitalier Et Universitaire De Clermont-Ferrand | Gelule a liberation gastro-intestinale destinee a etre utilisee dans une methode permettant de desensibiliser et/ou d'induire une tolerance chez un sujet allergique a l'arachide |
| TWI663979B (zh) * | 2018-03-20 | 2019-07-01 | 菲利達生技股份有限公司 | 用於抗發炎之套組 |
| IT201900006038A1 (it) | 2019-04-18 | 2020-10-18 | Fidia Farm Spa | Composizioni farmaceutiche comprendenti statine e derivati dell’acido ialuronico |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5095037B1 (en) * | 1989-12-21 | 1995-12-19 | Nissho Kk | Combined anti-inflammatory agent |
| WO2001037876A2 (en) * | 1999-11-24 | 2001-05-31 | Bayer Aktiengesellschaft | Methods of ameliorating abnormal bone states |
| US20040048910A1 (en) | 2002-08-22 | 2004-03-11 | Bove Susan Elizabeth | Method of treating osteoarthritis |
| EP1539127A1 (en) * | 2002-08-22 | 2005-06-15 | Warner-Lambert Company Llc | Method of treating osteoarthritis |
| US20070003636A1 (en) * | 2003-01-22 | 2007-01-04 | Francois Mach | Statins (HMG-COA reductase inhibitors) as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent |
| BRPI0418384A (pt) | 2003-05-30 | 2007-06-26 | Arc Pharmaceuticals Inc | composições farmacêuticas e métodos referentes à inibição de adesões fibrosas utilizando diversos agentes |
| CN1829501A (zh) | 2003-05-30 | 2006-09-06 | Arc药品有限公司 | 涉及使用多种药物抑制纤维粘连的药用组合物和方法 |
-
2010
- 2010-10-29 TW TW099137186A patent/TWI382841B/zh active
-
2011
- 2011-02-10 US US13/024,764 patent/US8691796B2/en active Active
- 2011-03-28 JP JP2011069623A patent/JP5513430B2/ja not_active Expired - Fee Related
- 2011-09-20 ES ES11181939.7T patent/ES2501040T3/es active Active
- 2011-09-20 PT PT111819397T patent/PT2446884E/pt unknown
- 2011-09-20 RS RSP20140489 patent/RS53546B1/en unknown
- 2011-09-20 SI SI201130266T patent/SI2446884T1/sl unknown
- 2011-09-20 DK DK11181939.7T patent/DK2446884T3/da active
- 2011-09-20 EP EP11181939.7A patent/EP2446884B1/en active Active
- 2011-09-20 PL PL11181939T patent/PL2446884T3/pl unknown
- 2011-09-23 CN CN2011102875733A patent/CN102462843A/zh active Pending
-
2012
- 2012-07-23 HK HK12107176.7A patent/HK1166468A1/xx not_active IP Right Cessation
-
2014
- 2014-09-05 HR HRP20140842AT patent/HRP20140842T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP5513430B2 (ja) | 2014-06-04 |
| RS53546B1 (en) | 2015-02-27 |
| EP2446884A1 (en) | 2012-05-02 |
| HRP20140842T1 (hr) | 2015-03-13 |
| CN102462843A (zh) | 2012-05-23 |
| ES2501040T3 (es) | 2014-10-01 |
| TW201216970A (en) | 2012-05-01 |
| US8691796B2 (en) | 2014-04-08 |
| JP2012097066A (ja) | 2012-05-24 |
| US20120108536A1 (en) | 2012-05-03 |
| PL2446884T3 (pl) | 2014-12-31 |
| PT2446884E (pt) | 2014-09-05 |
| EP2446884B1 (en) | 2014-06-25 |
| HK1166468A1 (en) | 2012-11-02 |
| TWI382841B (zh) | 2013-01-21 |
| DK2446884T3 (da) | 2014-09-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20140842T1 (hr) | Sastav za spreäśavanje upale, koji sadrži hijaluronsku kiselinu i inhibitor reduktaze hmg-coa | |
| HK1178742A1 (zh) | -亞硝基谷胱甘肽還原酶的新抑制劑 | |
| HK1253692A1 (zh) | 含有hdac抑制劑和環多醣的藥物組合物 | |
| IL223829A (en) | Quinoline compounds are produced as s-nitrosoglutathione reductase inhibitors | |
| PT2563771E (pt) | Compostos inibidores de metaloenzimas | |
| EP2638021A4 (en) | METALLOENZYMHEMMERVERBINDUNGEN | |
| EP2588474A4 (en) | PROCESS FOR PREPARING HMG-COA REDUCTASE INHIBITORS AND INTERMEDIATES THEREOF | |
| HRP20171390T1 (hr) | Inhibitor tolerancije na analgetike | |
| HK1156852A1 (en) | Pyrrole inhibitors of s-nitrosoglutathione reductase s- | |
| WO2012092202A9 (en) | Modulation of side effect profile of 5-alpha reductase inhibitor therapy | |
| EP2632903A4 (en) | METALLOENZYMHEMMERVERBINDUNGEN | |
| EP2651401A4 (en) | COMPOSITE PHARMACEUTICAL FORMULATION COMPRISING AN INHIBITOR OF HMG-COA REDUCTASE, AND ASPIRIN | |
| EP2651905A4 (en) | METALLOENZYMHEMMERVERBINDUNGEN | |
| EP2512247A4 (en) | NOVEL THIOPHEN INHIBITORS OF S-NITROSOGLUTATHIONE REDUCTASE | |
| IL215552A0 (en) | Substituted 4-amino-5-benzoyl-2-(phenylamino)thiophene-3- carbonitriles and substituted 4-amino-5-benzoyl-2-(phenylamino)thiophene-3-carboxamides as tubulin polymerization inhibitors | |
| GB201010218D0 (en) | Corrosion inhibitor | |
| AU2010901093A0 (en) | Evaporation inhibitor application | |
| AU2010900043A0 (en) | Metal coated steel strip | |
| ZA201006157B (en) | Modified release formulations of hmg coa reductase inhibitors | |
| IL214333A0 (en) | Carbamoylphosphonates as inhibitors and uses thereof | |
| AU2010904580A0 (en) | Non-toxic locust-flight inhibitor |